Report Detail
Global Transfusion Diagnosis for Donor Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4673597 |
- 16 February, 2026 |
- Global |
- 120 Pages |
- GIR |
- Service & Software
According to our (Global Info Research) latest study, the global Transfusion Diagnosis for Donor market size was valued at US$ 4630 million in 2025 and is forecast to a readjusted size of US$ 6686 million by 2032 with a CAGR of 5.4% during review period.
The gross profit margin of major companies in the industry is between 50% – 70%.
Transfusion Diagnosis for Donors refers to the critical medical screening and testing process performed on blood donors to ensure the safety and compatibility of blood products. This includes mandatory screening for transfusion-transmitted infections (TTIs) such as HIV, Hepatitis B and C, and Syphilis using Nucleic Acid Testing (NAT) and ELISA. It also encompasses blood group serology (ABO/Rh typing) and cross-matching. These procedures are fundamental to modern hemovigilance, ensuring every blood unit meets stringent clinical safety standards to prevent adverse reactions in recipients.
The industrial chain begins upstream with providers of biological raw materials (antigens, antibodies, enzymes), precision optical sensors, microfluidic chips, and high-purity reagents. The midstream consists of manufacturers of automated blood screening platforms, molecular diagnostic systems, and immunoassays. Downstream applications include national and regional blood centers, hospital blood banks, and plasma collection stations. The chain is supported by cold-chain logistics providers and regulatory bodies. Service providers offer calibration, system maintenance, and integrated blood management software to track blood units from collection to clinical transfusion, ensuring full traceability and safety.
The market for transfusion diagnosis is witnessing a significant shift toward automated and molecular-based testing to minimize the "window period" of infection detection. Increasing global healthcare expenditures and aging populations are driving the demand for safe blood supplies. A key trend is the integration of Nucleic Acid Testing (NAT) with traditional serology to enhance sensitivity. Furthermore, the adoption of Big Data and AI in blood management systems is optimizing inventory and reducing wastage. While stringent regulatory requirements pose a high entry barrier, the expansion of blood banking infrastructure in emerging economies provides substantial growth opportunities. Manufacturers are focusing on high-throughput systems that reduce manual errors while maintaining the highest levels of diagnostic accuracy and safety.
This report is a detailed and comprehensive analysis for global Transfusion Diagnosis for Donor market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transfusion Diagnosis for Donor market size and forecasts, in consumption value ($ Million), 2021-2032
Global Transfusion Diagnosis for Donor market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Transfusion Diagnosis for Donor market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Transfusion Diagnosis for Donor market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transfusion Diagnosis for Donor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transfusion Diagnosis for Donor market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Transfusion Diagnosis for Donor market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Instruments
Kits and Reagents
Market segment by Diagnostic Purpose
Blood Grouping & Typing Diagnostics
Infectious Disease Screening Diagnostics
Market segment by Testing Method
Immunoassay-Based Diagnostics
Molecular Diagnostics
Market segment by Application
Blood Banks
Blood Donation/Transfusion Centers
Others
Market segment by players, this report covers
Grifols
F. Hoffmann-La Roche
Abbott
Bio-Rad Laboratories
Werfen
QuidelOrtho Corporation
AliveDx Holdings Finance
BAG Diagnostics GmbH
Diasorin
Prestige Diagnostics
Atlas Medical GmbH
Lorne Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Transfusion Diagnosis for Donor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Transfusion Diagnosis for Donor, with revenue, gross margin, and global market share of Transfusion Diagnosis for Donor from 2021 to 2026.
Chapter 3, the Transfusion Diagnosis for Donor competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Transfusion Diagnosis for Donor market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transfusion Diagnosis for Donor.
Chapter 13, to describe Transfusion Diagnosis for Donor research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Transfusion Diagnosis for Donor by Type
- 1.3.1 Overview: Global Transfusion Diagnosis for Donor Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Transfusion Diagnosis for Donor Consumption Value Market Share by Type in 2025
- 1.3.3 Instruments
- 1.3.4 Kits and Reagents
- 1.4 Classification of Transfusion Diagnosis for Donor by Diagnostic Purpose
- 1.4.1 Overview: Global Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Transfusion Diagnosis for Donor Consumption Value Market Share by Diagnostic Purpose in 2025
- 1.4.3 Blood Grouping & Typing Diagnostics
- 1.4.4 Infectious Disease Screening Diagnostics
- 1.5 Classification of Transfusion Diagnosis for Donor by Testing Method
- 1.5.1 Overview: Global Transfusion Diagnosis for Donor Market Size by Testing Method: 2021 Versus 2025 Versus 2032
- 1.5.2 Global Transfusion Diagnosis for Donor Consumption Value Market Share by Testing Method in 2025
- 1.5.3 Immunoassay-Based Diagnostics
- 1.5.4 Molecular Diagnostics
- 1.6 Global Transfusion Diagnosis for Donor Market by Application
- 1.6.1 Overview: Global Transfusion Diagnosis for Donor Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Blood Banks
- 1.6.3 Blood Donation/Transfusion Centers
- 1.6.4 Others
- 1.7 Global Transfusion Diagnosis for Donor Market Size & Forecast
- 1.8 Global Transfusion Diagnosis for Donor Market Size and Forecast by Region
- 1.8.1 Global Transfusion Diagnosis for Donor Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global Transfusion Diagnosis for Donor Market Size by Region, (2021-2032)
- 1.8.3 North America Transfusion Diagnosis for Donor Market Size and Prospect (2021-2032)
- 1.8.4 Europe Transfusion Diagnosis for Donor Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific Transfusion Diagnosis for Donor Market Size and Prospect (2021-2032)
- 1.8.6 South America Transfusion Diagnosis for Donor Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa Transfusion Diagnosis for Donor Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Grifols
- 2.1.1 Grifols Details
- 2.1.2 Grifols Major Business
- 2.1.3 Grifols Transfusion Diagnosis for Donor Product and Solutions
- 2.1.4 Grifols Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Grifols Recent Developments and Future Plans
- 2.2 F. Hoffmann-La Roche
- 2.2.1 F. Hoffmann-La Roche Details
- 2.2.2 F. Hoffmann-La Roche Major Business
- 2.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product and Solutions
- 2.2.4 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
- 2.3 Abbott
- 2.3.1 Abbott Details
- 2.3.2 Abbott Major Business
- 2.3.3 Abbott Transfusion Diagnosis for Donor Product and Solutions
- 2.3.4 Abbott Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Abbott Recent Developments and Future Plans
- 2.4 Bio-Rad Laboratories
- 2.4.1 Bio-Rad Laboratories Details
- 2.4.2 Bio-Rad Laboratories Major Business
- 2.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product and Solutions
- 2.4.4 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Bio-Rad Laboratories Recent Developments and Future Plans
- 2.5 Werfen
- 2.5.1 Werfen Details
- 2.5.2 Werfen Major Business
- 2.5.3 Werfen Transfusion Diagnosis for Donor Product and Solutions
- 2.5.4 Werfen Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Werfen Recent Developments and Future Plans
- 2.6 QuidelOrtho Corporation
- 2.6.1 QuidelOrtho Corporation Details
- 2.6.2 QuidelOrtho Corporation Major Business
- 2.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product and Solutions
- 2.6.4 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 QuidelOrtho Corporation Recent Developments and Future Plans
- 2.7 AliveDx Holdings Finance
- 2.7.1 AliveDx Holdings Finance Details
- 2.7.2 AliveDx Holdings Finance Major Business
- 2.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product and Solutions
- 2.7.4 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 AliveDx Holdings Finance Recent Developments and Future Plans
- 2.8 BAG Diagnostics GmbH
- 2.8.1 BAG Diagnostics GmbH Details
- 2.8.2 BAG Diagnostics GmbH Major Business
- 2.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product and Solutions
- 2.8.4 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 BAG Diagnostics GmbH Recent Developments and Future Plans
- 2.9 Diasorin
- 2.9.1 Diasorin Details
- 2.9.2 Diasorin Major Business
- 2.9.3 Diasorin Transfusion Diagnosis for Donor Product and Solutions
- 2.9.4 Diasorin Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Diasorin Recent Developments and Future Plans
- 2.10 Prestige Diagnostics
- 2.10.1 Prestige Diagnostics Details
- 2.10.2 Prestige Diagnostics Major Business
- 2.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Product and Solutions
- 2.10.4 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Prestige Diagnostics Recent Developments and Future Plans
- 2.11 Atlas Medical GmbH
- 2.11.1 Atlas Medical GmbH Details
- 2.11.2 Atlas Medical GmbH Major Business
- 2.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Product and Solutions
- 2.11.4 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Atlas Medical GmbH Recent Developments and Future Plans
- 2.12 Lorne Laboratories
- 2.12.1 Lorne Laboratories Details
- 2.12.2 Lorne Laboratories Major Business
- 2.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Product and Solutions
- 2.12.4 Lorne Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Lorne Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Transfusion Diagnosis for Donor Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Transfusion Diagnosis for Donor by Company Revenue
- 3.2.2 Top 3 Transfusion Diagnosis for Donor Players Market Share in 2025
- 3.2.3 Top 6 Transfusion Diagnosis for Donor Players Market Share in 2025
- 3.3 Transfusion Diagnosis for Donor Market: Overall Company Footprint Analysis
- 3.3.1 Transfusion Diagnosis for Donor Market: Region Footprint
- 3.3.2 Transfusion Diagnosis for Donor Market: Company Product Type Footprint
- 3.3.3 Transfusion Diagnosis for Donor Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Transfusion Diagnosis for Donor Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Transfusion Diagnosis for Donor Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Transfusion Diagnosis for Donor Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Transfusion Diagnosis for Donor Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Transfusion Diagnosis for Donor Consumption Value by Type (2021-2032)
- 6.2 North America Transfusion Diagnosis for Donor Market Size by Application (2021-2032)
- 6.3 North America Transfusion Diagnosis for Donor Market Size by Country
- 6.3.1 North America Transfusion Diagnosis for Donor Consumption Value by Country (2021-2032)
- 6.3.2 United States Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 6.3.3 Canada Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Transfusion Diagnosis for Donor Consumption Value by Type (2021-2032)
- 7.2 Europe Transfusion Diagnosis for Donor Consumption Value by Application (2021-2032)
- 7.3 Europe Transfusion Diagnosis for Donor Market Size by Country
- 7.3.1 Europe Transfusion Diagnosis for Donor Consumption Value by Country (2021-2032)
- 7.3.2 Germany Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 7.3.3 France Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 7.3.5 Russia Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 7.3.6 Italy Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Transfusion Diagnosis for Donor Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Transfusion Diagnosis for Donor Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Region
- 8.3.1 Asia-Pacific Transfusion Diagnosis for Donor Consumption Value by Region (2021-2032)
- 8.3.2 China Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 8.3.3 Japan Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 8.3.5 India Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 8.3.7 Australia Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Transfusion Diagnosis for Donor Consumption Value by Type (2021-2032)
- 9.2 South America Transfusion Diagnosis for Donor Consumption Value by Application (2021-2032)
- 9.3 South America Transfusion Diagnosis for Donor Market Size by Country
- 9.3.1 South America Transfusion Diagnosis for Donor Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Transfusion Diagnosis for Donor Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Transfusion Diagnosis for Donor Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country
- 10.3.1 Middle East & Africa Transfusion Diagnosis for Donor Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
- 10.3.4 UAE Transfusion Diagnosis for Donor Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Transfusion Diagnosis for Donor Market Drivers
- 11.2 Transfusion Diagnosis for Donor Market Restraints
- 11.3 Transfusion Diagnosis for Donor Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Transfusion Diagnosis for Donor Industry Chain
- 12.2 Transfusion Diagnosis for Donor Upstream Analysis
- 12.3 Transfusion Diagnosis for Donor Midstream Analysis
- 12.4 Transfusion Diagnosis for Donor Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Transfusion Diagnosis for Donor. Industry analysis & Market Report on Transfusion Diagnosis for Donor is a syndicated market report, published as Global Transfusion Diagnosis for Donor Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Transfusion Diagnosis for Donor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
